糖尿病、肥満および関連障害の治療のためのＧＰＲ１１９モジュレーターとしての縮合ジヒドロフラン

摘要

The present invention relates to compounds of general formula I, wherein the groups R1, LP, LQ, X1, X2, X3, A, n and m are as defined in the application. The compounds of formula I have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.